glycine has been researched along with Parkinson Disease, Secondary in 9 studies
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zheng, Q | 1 |
| Yin, J | 1 |
| Zhu, L | 1 |
| Jiao, L | 1 |
| Xu, Z | 1 |
| Lesage, S | 1 |
| Anheim, M | 1 |
| Letournel, F | 1 |
| Bousset, L | 1 |
| Honoré, A | 1 |
| Rozas, N | 1 |
| Pieri, L | 1 |
| Madiona, K | 1 |
| Dürr, A | 1 |
| Melki, R | 1 |
| Verny, C | 1 |
| Brice, A | 1 |
| Imaoka, T | 1 |
| Date, I | 1 |
| Ohmoto, T | 1 |
| Nagatsu, T | 1 |
| Dawson, L | 1 |
| Chadha, A | 1 |
| Megalou, M | 1 |
| Duty, S | 1 |
| Miwa, H | 1 |
| Nishi, K | 1 |
| Fuwa, T | 1 |
| Mizuno, Y | 1 |
| Schneider, JS | 1 |
| Tinker, JP | 1 |
| Van Velson, M | 1 |
| Giardiniere, M | 1 |
| Barbosa, ER | 1 |
| Leiros da Costa, MD | 1 |
| Bacheschi, LA | 1 |
| Scaff, M | 1 |
| Leite, CC | 1 |
| Gründig, E | 2 |
| Raheem, KA | 1 |
| Salvenmoser, F | 1 |
| Schedl, R | 1 |
| Weiss, J | 1 |
| Hanbauer, I | 1 |
9 other studies available for glycine and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Reversible Parkinsonism induced by acute exposure glyphosate.
Topics: Female; Glycine; Glyphosate; Herbicides; Humans; Middle Aged; Parkinson Disease, Secondary | 2018 |
G51D α-synuclein mutation causes a novel parkinsonian-pyramidal syndrome.
Topics: Adult; Aged; Aged, 80 and over; alpha-Synuclein; Amyloid; Aspartic Acid; Blepharospasm; Caspase 3; D | 2013 |
Significant behavioral recovery in Parkinson's disease model by direct intracerebral gene transfer using continuous injection of a plasmid DNA-liposome complex.
Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Bovine papillomavirus 1; Cattle; Disease Models, Anim | 1998 |
The group II metabotropic glutamate receptor agonist, DCG-IV, alleviates akinesia following intranigral or intraventricular administration in the reserpine-treated rat.
Topics: Animals; Anticonvulsants; Antipsychotic Agents; Cyclopropanes; Dyskinesia, Drug-Induced; Glycine; In | 2000 |
Effects of blockade of metabotropic glutamate receptors in the subthalamic nucleus on haloperidol-induced Parkinsonism in rats.
Topics: Animals; Benzoates; Dopamine Antagonists; Dystonia; Excitatory Amino Acid Antagonists; Glycine; Halo | 2000 |
Effects of the partial glycine agonist D-cycloserine on cognitive functioning in chronic low dose MPTP-treated monkeys.
Topics: Animals; Cognition; Cycloserine; Discrimination, Psychological; Disease Models, Animal; Dizocilpine | 2000 |
Parkinsonism after glycine-derivate exposure.
Topics: Antiparkinson Agents; Benserazide; Drug Therapy, Combination; Globus Pallidus; Glycine; Glyphosate; | 2001 |
Drug-induced parkinsonism in the rat- a model for biochemical investigation of the parkinson-syndrome. III. The incorporation of D-glucose-14C(U) in amino acids of brain and liver from rats pretreated with reserpine or with phenothiazines.
Topics: Amino Acids; Animals; Antipsychotic Agents; Brain; Glucose; Glutamates; Glutamine; Glycine; Liver; M | 1976 |
[Brain aminoacids in phenothiazin-induced Parkinsonism. Drug-induced parkinsonism in the rat--a model for biochemical studies of the Parkinson-syndrome].
Topics: Amino Acids; Aminobutyrates; Animals; Basal Ganglia; Brain; Cerebellum; Cerebral Cortex; Chromatogra | 1970 |